0000914190-20-000249.txt : 20200807 0000914190-20-000249.hdr.sgml : 20200807 20200807185025 ACCESSION NUMBER: 0000914190-20-000249 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200805 FILED AS OF DATE: 20200807 DATE AS OF CHANGE: 20200807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hippel James CENTRAL INDEX KEY: 0001603594 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 201085955 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-08-05 0000842023 BIO-TECHNE Corp TECH 0001603594 Hippel James 614 MCKINLEY PLACE N.E. MINNEAPOLIS MN 55413 0 1 0 0 Chief Financial Officer Common Stock 6883 D Stock Options (Right to Buy) 108.49 2022-08-07 Common Stock 15909 15909 D Stock Options (Right to Buy) 106.59 2023-08-18 Common Stock 30400 30400 D Stock Options (Right to Buy) 106.59 2023-08-18 Common Stock 40533 40533 D Restricted Stock Units Common Stock 4438 4438 D Stock Options (Right to Buy) 125.05 2024-08-09 Common Stock 24460 24460 D Stock Options (Right to Buy) 125.05 2024-08-09 Common Stock 32613 32613 D Restricted Stock Units Common Stock 3383 3383 D Stock Options (Right to Buy) 177.32 2025-08-08 Common Stock 18066 18066 D Stock Options (Right to Buy) 177.32 2025-08-08 Common Stock 24089 24089 D Restricted Stock Units Common Stock 3938 3938 D Stock Options (Right to Buy) 190.41 2026-08-07 Common Stock 19936 19936 D Stock Options (Right to Buy) 190.41 2026-08-07 Common Stock 26581 26581 D Restricted Stock Units 2020-08-05 4 A 0 3219 0 A Common Stock 3219 3219 D Stock Options (Right to Buy) 267.87 2020-08-05 4 A 0 14360 0 A 2027-08-05 Common Stock 14360 14360 D Stock Options (Right to Buy) 267.87 2020-08-05 4 A 0 19147 0.0 A 2027-08-05 Common Stock 19147 19147 D Stock Options (Right to Buy) 267.87 2020-08-05 4 A 0 8325 0.0 A 2027-08-05 Common Stock 8325 8325 D Stock Options (Right to Buy) 267.87 2020-08-05 4 A 0 8325.0 0.0 A 2027-08-05 Common Stock 8325.0 8325.0 D Reflects a correction to the previously-reported number. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. Fully exercisable. Options to purchase 10,134 shares vest on 8/18/2017 and options to purchase 10,133 shares vest on each of 8/18/2018, 8/18/2019 and 8/18/2020. Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 8,153 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and options to purchase 8,154 shares vest on 8/9/2021. Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 6,023 shares vest on 8/8/2019 and options to purchase 6,022 shares vest on each of 8/8/2020, 8/8/2021 and 8/8/2022. Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 6,646 shares vest on 8/7/2020 and options to purchase 6,645 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023. Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 4,787 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023 and options to purchase 4,786 shares vest on 8/5/2024. Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023. Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021 /s/ Brenda S. Furlow, Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed. 2020-08-07